Skip Navigation
< Back
QualityTool

2006 Update of the ASCO Recommendations for Antiemetics in Oncology: Guideline Summary


Description

This three-page guideline summary is a 2006 update of the American Society of Clinical Oncology's (ASCO) recommendations for the use of antiemetics in oncology.

This guideline summary addresses the following topics:

  • Chemotherapy-induced emesis
  • Radiation-induced emesis

Three tables summarize the following topics:

  • Antiemetic agents and regimens, emetic risk categories, special emetic problems, and radiation-induced emesis
  • Emetic risk of intravenously administered antineoplastic agents
  • Emetic risk of radiation regimens

A discussion, a description of the methodology, and information about additional resources are also presented.

Links to the Tool:
This tool is available at: http://jop.ascopubs.org/content/2/4/193.full

Developer

American Society of Clinical Oncology

Funding Sources

American Society of Clinical Oncology


QualityTool Topic

Guideline-Related; Patient/Medication safety


Links to National Guideline Clearinghouse or National Quality Measures Clearinghouse:

This tool is derived from the following guideline in the National Guideline Clearinghouse (NGC): American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006:
http://www.guideline.gov/summary/summary.aspx?ss=15&doc_id=9372&string=

History

  • Release Date: 07/2006
  • Original Summary: 08/2006
Disclaimer: The inclusion of a tool in the Innovations Exchange does not constitute or imply an endorsement by the U.S. Department of Health and Human Services, the Agency for Healthcare Research and Quality or Westat of the tool or of the submitter or developer of the tool. Read more.
QualityTool Classification

Stage of Care:
Setting of Care:
IOM Domains of Quality:
QualityTool Format:

Last updated: February 16, 2011.